Current Drugs Strategies for Treatment of Rare Neurodegenerative Diseases (original) (raw)

Need to improve clinical trials in rare neurodegenerative disorders

maria puopolo

2011

View PDFchevron_right

Drug treatment of Parkinson’s disease

benjamin drukarch

Biochemical Pharmacology, 2000

View PDFchevron_right

Maraula et al. Neuropharmacol. 2012

Felicita Pedata

View PDFchevron_right

Application of Precision Medicine in Neurodegenerative Diseases

silvestro mauriello

Frontiers in Neurology, 2018

View PDFchevron_right

Novel Therapeutic Strategies for Alzheimer??S Disease and Related Disorders

Soraya Sajadimajd

Alzheimer Disease & Associated Disorders, 1988

View PDFchevron_right

Natural Products in Treatment of Neurological Disorders

Shalini Mani

Indo global journal of pharmaceutical sciences, 2017

View PDFchevron_right

Therapeutics in Huntington’s Disease

Kevin Biglan

Current Treatment Options in Neurology, 2012

View PDFchevron_right

Abstracts Second Congress of the European Society for Clinical Neuropharmacology

A. Seghers

Journal of Neural Transmission, 1995

View PDFchevron_right

Foundation review: Translational CNS medicines research

Alan Palmer

2012

View PDFchevron_right

Current and novel therapeutic molecules and targets in Alzheimer's disease

Timir Tripathi

Journal of the Formosan Medical Association, 2016

View PDFchevron_right

Neurodegenerations are diseases of the present and the future

Ewa Gorodkiewicz

Journal of Education, Health and Sport, 2022

View PDFchevron_right

Precision Nanomedicine in Neurodegenerative Diseases

Meir Goldsmith

ACS Nano, 2014

View PDFchevron_right

Emerging drugs for epilepsy and other treatment options

Bernhard Steinhoff

European Journal of Neurology, 2007

View PDFchevron_right

A New Regulatory Road-Map for Alzheimer’s Disease Drug Development

Nigel Greig

Current Alzheimer Research, 2014

View PDFchevron_right

Prominent Medicinal Plants for the Treatment of Neurodegenerative Disorders

Ifraha Abbas

2022

View PDFchevron_right

Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Yuen So

2008

View PDFchevron_right

Alzheimer’s disease therapies: Selected advances and future perspectives

Abdelaziz Ghanemi, PhD

Alexandria Journal of Medicine, 2015

View PDFchevron_right

Editorial: New challenges and future perspectives in neurodegeneration

Hamid R Sohrabi

Frontiers in Neuroscience, 2022

View PDFchevron_right

Nanomedicine and Nano Formulations for Neurodegenerative Diseases

Yashwant Pathak

Biomedical Journal of Scientific & Technical Research

View PDFchevron_right

Treatment of Alzheimer's disease across the spectrum of severity

Shailaja Shah

Clinical Interventions in Aging, 2006

View PDFchevron_right

Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy

Renee Arnold

F1000Research, 2014

View PDFchevron_right

Neuroprotective agents target molecular mechanisms of disease in ALS

Lilly Mao

Drug Discovery Today, 2015

View PDFchevron_right

Emerging Therapies in the Pharmacological Treatment of Parkinson???s Disease

Amos Korczyn

Drugs, 2002

View PDFchevron_right

Antiemetic Medications: Agents, Current Research, and Future Directions

Ali Sulieman

2019

View PDFchevron_right

Herbal nutraceuticals in health and neurodegenerative diseases

Grace Ababio

2023

View PDFchevron_right

A novel approach for integrative studies on neurodegenerative diseases in human brains

Wilson Jacob-filho

Journal of Neuroscience Methods, 2014

View PDFchevron_right

Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders

Ulrich Eisel

Antibodies, 2015

View PDFchevron_right

Guideline on the clinical investigation of medicines for the treatment of Alzheimer’s disease

Maria Barcikowska

2018

View PDFchevron_right

Behind a Great Drug There Is a Great Scientist: The Discovery of a Treatment for Parkinson’s Disease

Jolanta Opacka-Juffry

Frontiers for Young Minds, 2020

View PDFchevron_right

New Therapeutic Strategies and Drug Candidates for Neurodegenerative Diseases: p53 and TNF- Inhibitors, and GLP-1 Receptor Agonists

Nigel Greig

Annals of the New York Academy of Sciences, 2004

View PDFchevron_right

Novel therapies for Duchenne muscular dystrophy

Robert Kapsa

The Lancet Neurology, 2003

View PDFchevron_right

Treating Neurodegenerative Conditions Through the Understanding of Neuronal Apoptosis

Santosh D'Mello

Current Drug Target -CNS & Neurological Disorders, 2005

View PDFchevron_right

A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis

gilbert bensimon

Journal of Neurology, 2002

View PDFchevron_right

Therapeutic effects of natural antioxidant on neurodegenerative disease

Sandra Orozco-suarez

View PDFchevron_right

Challenges with advanced therapy medicinal products and how to meet them

Marit Hystad

Nature Reviews Drug Discovery, 2010

View PDFchevron_right